Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 122 results for "Mk 5172"

Merck's hep C drugs to lose breakthrough status
CNBC

MERCK & CO., INC. - 10-K - Management's Discussion and Analysi...

Description of Merck's Business Merck & Co., Inc. ("Merck" or the "Company") is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products, which ... Pharmacy Choice, 6 days ago
[x]  
Gizmodo

Hunting a Silent Killer: How to Cure Hepatitis C in the Undiagnosed

Hepatitis C has a cure, but how do we find those who need it? Patrick Strudwick reports on one attempt to identify some of the estimated 100,000 undiagnosed people in the UK. A young woman jeans and boots and wild hair is sitting in a cubicle ...
 Gizmodo2 weeks ago
Motley Fool

In Case You Missed It, There's a New Fastest Growing Drug in the World

Ladies and gentlemen, for the third time in less than four years we've witnessed the fastest growing drug in the world get unseated. A walk down memory lane As a refresher, in May 2011, the Food and Drug Administration approved a revolutionary new ...
 Motley Fool2 weeks ago
Motley Fool

1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep

Earnings season is more than halfway over, and it hasn't been easy to keep pace with hundreds upon hundreds of earnings reports, sometimes all hitting within the same day. Much of the healthcare sector, especially big pharmaceutical companies, ...
 Motley Fool3 weeks ago
Citybizlist

Merck & Co., Inc. Earnings: 1 Sentence That Changed Everything

Put plainly, Wall Street and investors aren't too happy with pharmaceutical giant Merck (NYSE: MRK Merck's top-line takes a beating For the quarter, Merck watched as its total revenue slumped 7% to $10.48 billion from $11.32 billion in Q4 2013.
 Motley Fool4 weeks ago

FDA to retract breakthrough therapy designation of grazoprevir/elbasvir combo for HCV

The FDA plans to retract breakthrough therapy designation status for the combination regimen of grazoprevir and elbasvir to treat chronic hepatitis C virus infection, according to 2014 financial results released by Merck. According to the ...
 Orthopedics Today4 weeks ago Breakthroughs Aren't Forever  Corante4 weeks ago

Financial Highlights Package

By Business Wire | 02/04/15 - 07:02 AM EST Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2014. Fourth Quarter Year Ended ...
 TheStreet.com4 weeks ago Merck Announces Fourth-Quarter and Full-Year 2014 Financial Results  CNBC4 weeks ago Merck : Announces Fourth-Quarter and Full-Year 2014 Financial Results  4 Traders4 weeks ago Merck & Co drops marketing of hepatitis C drug Victrelis in USA  Pharma Letter1 month ago
[x]  

FDA yanks 'breakthrough' bragging rights to Merck's hep C combo

Now that AbbVie ($ABBV) has followed up on Gilead's ($GILD) game-changing hep C combo with its own directly competitive cocktail, Merck's late-stage player in the field doesn't look quite as revolutionary as it once did. With a new drug application ...
 FierceBiotech4 weeks ago FDA yanking 'breakthrough' bragging rights to Merck's hep C combo  FierceBiotech4 weeks ago

N-Terminal and C-Terminal Domains of Calmodulin Mediate FADD and TRADD Interaction

Abstract FADD (Fasassociated death domain) and TRADD (Tumor Necrosis Factor Receptor 1-associated death domain) proteins are important regulators of cell fate in mammalian cells. They are both involved in death receptors mediated signaling pathways ...
 Plosone.org1 month ago

IFN-free Therapy in Treatment-naive Patients With HCV

Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatol 2002; 36(5 Suppl. 1): S4756. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.
 General Medicine eJournal1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less